Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Eton Pharmaceuticals (Nasdaq: ETON) announced it will report third quarter 2025 financial results on Thursday, November 6, 2025. Management will host a conference call and live audio webcast at 4:30 p.m. ET (3:30 p.m. CT) to discuss results and take live and emailed investor questions.
Investors may submit questions to investorrelations@etonpharma.com. The live webcast is available on the company investor website at https://ir.etonpharma.com/. An archived webcast will be posted approximately two hours after the event and remain available for 30 days.
Eton Pharmaceuticals (Nasdaq: ETON) ha annunciato che renderà noti i risultati finanziari del terzo trimestre 2025 giovedì 6 novembre 2025. La direzione terrà una conference call e una webcast in diretta alle 16:30 ET (15:30 CT) per discutere i risultati e raccogliere domande da investitori inviate dal vivo e via email.
Gli investitori possono inviare domande a investorrelations@etonpharma.com. La webcast in diretta è disponibile sul sito degli investitori dell'azienda all'indirizzo https://ir.etonpharma.com/. Un webcast archiviato sarà pubblicato circa due ore dopo l'evento e rimarrà disponibile per 30 giorni.
Eton Pharmaceuticals (Nasdaq: ETON) anunció que reportará los resultados financieros del tercer trimestre de 2025 el jueves 6 de noviembre de 2025. La dirección organizará una conferencia telefónica y una transmisión en vivo por audio a las 4:30 p.m. hora del Este (3:30 p.m. hora del Centro) para discutir los resultados y recibir preguntas de los inversores en vivo y por correo electrónico.
Los inversores pueden enviar preguntas a investorrelations@etonpharma.com. La transmisión en vivo está disponible en el sitio web de inversores de la empresa en https://ir.etonpharma.com/. Una transmisión archivada estará disponible aproximadamente dos horas después del evento y permanecerá disponible durante 30 días.
Eton Pharmaceuticals (Nasdaq: ETON) 은 2025년 3분기 재무 실적을 2025년 11월 6일 목요일에 발표한다고 발표했습니다. 경영진은 결과를 논의하고 실시간으로 주주들의 질문을 받기 위해 ET 기준 오후 4시 30분(중부 표준시 3시 30분)에 전화 회의와 라이브 Audio 웹캐스트를 진행합니다.
투자자는 investorrelations@etonpharma.com으로 질문을 보낼 수 있습니다. 라이브 웹캐스트는 회사의 투자자 웹사이트 https://ir.etonpharma.com/에서 이용 가능하며, 아카이브 웹캐스트는 이벤트 종료 약 두 시간 후에 게시되고 30일 동안 이용 가능합니다.
Eton Pharmaceuticals (Nasdaq : ETON) a annoncé qu'il publiera les résultats financiers du troisième trimestre 2025 le jeudi 6 novembre 2025. La direction animera une conférence téléphonique et une webdiffusion audio en direct à 16h30 HE (15h30 CT) pour discuter des résultats et répondre aux questions des investisseurs en direct et par e-mail.
Les investisseurs peuvent soumettre leurs questions à investorrelations@etonpharma.com. La webdiffusion en direct est disponible sur le site des investisseurs de l'entreprise à https://ir.etonpharma.com/. Une webdiffusion archivées sera publiée environ deux heures après l'événement et restera disponible pendant 30 jours.
Eton Pharmaceuticals (Nasdaq: ETON) hat angekündigt, die Ergebnisse des dritten Quartals 2025 am Donnerstag, dem 6. November 2025 zu berichten. Das Management wird einen Telefonkonferenz-Anruf und eine Live-Audio-Webcast um 16:30 Uhr ET (15:30 Uhr CT) abhalten, um die Ergebnisse zu besprechen und Live- sowie per E-Mail gestellte Investorenfragen zu beantworten.
Investoren können Fragen an investorrelations@etonpharma.com senden. Der Live-Webcast ist auf der Investorenwebsite des Unternehmens unter https://ir.etonpharma.com/ verfügbar. Ein archivierter Webcast wird etwa zwei Stunden nach der Veranstaltung veröffentlicht und bleibt 30 Tage lang verfügbar.
Eton Pharmaceuticals (Nasdaq: ETON) أعلنت أنها ستعلن عن نتائجها المالية للربع الثالث من عام 2025 يوم الخميس 6 نوفمبر 2025. ستستضيف الإدارة مكالمة مؤتمر وبثًا صوتيًا مباشرًا عبر الويب في السابعة والنصف مساءً بتوقيت شرق الولايات المتحدة (4:30 مساءً بتوقيت الوسط) لمناقشة النتائج وتلقي أسئلة المستثمرين مباشرًة وبالبريد الإلكتروني.
يمكن للمستثمرين إرسال أسئلة إلى investorrelations@etonpharma.com. يتاح البث المباشر عبر الويب على موقع المستثمرين بالشركة على https://ir.etonpharma.com/. وسيُنشَر البث المسجَّل بعد حوالي ساعتين من الحدث وسيظل متاحًا لمدة 30 يومًا.
Eton Pharmaceuticals（纳斯达克股票代码：ETON）宣布将于2025年11月6日（星期四）公布2025年第三季度的财务业绩。管理层将于美东时间 下午4:30（中部时间 下午3:30）举行电话会议和实时音频网络广播，以讨论业绩并现场及通过电子邮件回答投资者的问题。
投资者可将问题发送至 investorrelations@etonpharma.com。实时网络广播可在公司投资者网站 https://ir.etonpharma.com/ 上观看。归档网络广播将大约在活动结束后 两小时发布，并将保留 30天。
- None.
- None.
DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2025 financial results on Thursday, November 6, 2025. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).
| Participant Call Link: | Click Here |
| Webcast: | Click Here |
In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.
The live webcast can also be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.
About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX®, ALKINDI SPRINKLE®, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ET-600, Amglidia®, ET-700, ET-800 and ZENEO® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.
Investor Relations:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: Eton Pharmaceuticals, Inc.
FAQ
When will Eton Pharmaceuticals (ETON) release its Q3 2025 results?
What time is the ETON Q3 2025 earnings call and webcast?
How can investors join the ETON Q3 2025 webcast?
Can investors submit questions before Eton's November 6, 2025 call?
When will the Eton (ETON) webcast be available on demand after the call?
Will Eton discuss financial results and take live questions on the November 6, 2025 call?
